Clinical Trial

Probiotics for Anxiety Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to observe the effect of a consumer-grade probiotic capsule called GABA (gamma-aminobutyric acid ) Probiotic ("Study Product"), a probiotic capsule containing Lactiplantibacillus plantarum 815, on anxiety. The purpose of this study is to evaluate the effects of 2 different doses of this probiotic study product on anxiety in comparison to placebo. Additionally, the study aims to observe the effects of the probiotic study product on mood, cognitive function, quality of life and sleep. After the 6-week study product use period, all participants will be given the option to continue using GABA Probiotic for an additional 4 weeks. Participants in this study will complete surveys and questionnaires about their experience before, during and after taking the study product. Additionally, this study will incorporate the use of a wrist-worn electronic device to measure sleep.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-18.
Trial Details
NCT Number NCT06466603
Lead Sponsor Verb Biotics LLC
Collaborators: People Science, Inc.
Conditions Anxiety
Enrollment 122 participants
Start Date 2024-03-04
Primary Completion 2024-06-11 (estimated)
Study Completion 2025-02-11 (estimated)
Updated on ClinicalTrials.gov 2024-11-14